Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/42036
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSmeets , Miek-
dc.contributor.authorRaat, Willem-
dc.contributor.authorAertgeerts, Bert-
dc.contributor.authorPENDERS, Joris-
dc.contributor.authorVercammen, Jan-
dc.contributor.authorDroogne, Walter-
dc.contributor.authorMULLENS, Wilfried-
dc.contributor.authorJanssens , Stefan-
dc.contributor.authorVaes, Bert-
dc.date.accessioned2024-01-05T08:15:38Z-
dc.date.available2024-01-05T08:15:38Z-
dc.date.issued2023-
dc.date.submitted2024-01-05T07:20:45Z-
dc.identifier.citationESC Heart Failure, 10 (2) , p. 907 -916-
dc.identifier.urihttp://hdl.handle.net/1942/42036-
dc.description.abstractAimsHeart failure (HF) is an important health problem for which multidisciplinary care is recommended, yet few studies involve primary care practitioners in the multidisciplinary management of HF. We set up a multifaceted prospective observational trial, OSCAR-HF, piloting audit and feedback, natriuretic peptide testing at the point of care, and the assistance of a specialist HF nurse in primary care. The aim was to optimize HF care in general practice. Methods and resultsThis is an analysis at 6 month follow-up of the study interventions of the OSCAR-HF pilot study, a nonrandomized, noncontrolled prospective observational trial conducted in eight Belgian general practices [51 general practitioners (GPs)]. Patients who were assessed by their GP to have HF constituted the OSCAR-HF study population. We used descriptive statistics and mixed-effects modelling for the quantitative analysis and thematic analysis of the focus group interviews. There was a 10.2% increase in the registered HF population after 6 months of follow-up (n = 593) compared with baseline (n = 538) and a 27% increase in objectified HF diagnoses (baseline n = 359 to 456 at T6 M). Natriuretic peptide testing (with or without referral) accounted for 54% (n = 60/111) of the newly registered HF diagnoses. There was no difference in the proportion of patients with HF with reduced ejection fraction who received their target dosage of renin-angiotensin-aldosterone system inhibitors or beta-blockers at 6 months compared with baseline (P = 0.9). Patients who received an HF nurse intervention (n = 53) had significantly worse quality of life at baseline [difference in Minnesota Living with Heart Failure Questionnaire (MLHFQ) score 9.2 points; 95% confidence interval (CI) 4.0, 14] and had a significantly greater improvement in quality-of-life scores at the 6 month follow-up [change in MLHFQ score -9.8 points; 95% CI -15, -4.5] than patients without an HF nurse intervention. GPs found audit and feedback valuable but time intensive. Natriuretic peptides were useful, but the point-of-care test was impractical, and the assistance of an HF nurse was a useful addition to routine HF care. ConclusionsThe use of audit and feedback combined with natriuretic peptide testing was a successful strategy to increase the number of registered and objectified HF diagnoses at 6 months. GPs and HF nurses selected patients with worse quality-of-life scores at baseline for the HF nurse intervention, which led to a significantly greater improvement in quality-of-life scores at the 6 month follow-up compared with patients without an HF nurse intervention. The interventions were deemed feasible and useful by the participating GPs with some specific remarks that can be used for optimization.Trial Registration: (NCT02905786), registered on 14 September 2016 at .-
dc.description.sponsorshipMiek Smeets was funded by the Department of Cardiovascular Diseases, UZ Leuven (KUL), and by the Department of Public Health and Primary Care (KUL). Willem Raat was funded by the Department of Public Health and Primary Care (KUL). Jan Vercammen (HF nurse) was funded by the Department of Cardiovascular Diseases, ZOL Genk. Support for study personnel in the Leuven region was provided by an unrestricted research grant financed by Novartis (S54755). Roche Diagnostics provided the NT-proBNP POC devices. Novartis and Roche had a role in the design of this study, and they did not have any role during execution, analyses, interpretation of the data, or decision to submit the results of this study. Miek Smeets was rewarded for her work by the Viviane Conraads Price in 2017. We would like to thank Novartis and Roche Diagnostics for their support. We acknowledge Jan Vercammen, Anne Strijckmans, Christine Hellemans, and Lien Sevenants for their cooperation as heart failure nurses and Maaike Beckx as an assisting data manager. We acknowledge Dr Walter Droogne (UZ Leuven), Dr Hendrik Celen (Heilig Hart Leuven), Dr Philippe Stas (AZ Vesalius), and Dr Philippe Timmermans Jr (Virga Jessa Hasselt) as cooperating cardiologists and Dr Katleen Fagard (geriatrician) and Dr Agnieszka Ciarka (cardiologist) as members of our expert panel. Additionally, we would like to thank Prof. Dr Joris Penders and his team at ZOL Genk for acting as POC coordinators. Furthermore, we give a special acknowledgement to all participating general practices, Doktershuis (Bilzen), De Vlier (Riemst), De Hoeksteen (Eigenbilzen – Mopertingen), De Zeshoek (Munsterbilzen), Bleyenbergh (Wilsele), UGP (Leuven), Brugberg (Kessel-Lo), and De Vest (Leuven), and to all patients.-
dc.language.isoen-
dc.publisherWILEY PERIODICALS, INC-
dc.rights2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.-
dc.subject.otherHeart failure-
dc.subject.otherHeart failure-
dc.subject.otherDisease management programme-
dc.subject.otherDisease management programme-
dc.subject.otherGeneral practice-
dc.subject.otherGeneral practice-
dc.subject.otherMultidisciplinary chronic care-
dc.subject.otherMultidisciplinary chronic care-
dc.subject.otherNatriuretic peptides-
dc.subject.otherNatriuretic peptides-
dc.subject.otherAudit and feedback-
dc.subject.otherAudit and feedback-
dc.subject.otherPrimary care-
dc.subject.otherPrimary care-
dc.titleMixed-methods evaluation of a multifaceted heart failure intervention in general practice: the OSCAR-HF pilot study-
dc.typeJournal Contribution-
dc.identifier.epage916-
dc.identifier.issue2-
dc.identifier.spage907-
dc.identifier.volume10-
local.format.pages10-
local.bibliographicCitation.jcatA1-
dc.description.notesSmeets, M (corresponding author), Katholieke Univ Leuven, Dept Publ Hlth & Primary Care, Kapucijnenvoer 7,Blok D Bus 7001, B-3000 Leuven, Belgium.-
dc.description.notesmiek.smeets@kuleuven.be-
local.publisher.placeONE MONTGOMERY ST, SUITE 1200, SAN FRANCISCO, CA 94104 USA-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.identifier.doi10.1002/ehf2.14251-
dc.identifier.pmid36461750-
dc.identifier.isi001119955800001-
dc.contributor.orcidAertgeerts, Bert/0000-0003-1142-5402-
local.provider.typewosris-
local.description.affiliation[Smeets, Miek; Raat, Willem; Aertgeerts, Bert; Vaes, Bert] Katholieke Univ Leuven, Dept Publ Hlth & Primary Care, Kapucijnenvoer 7,Blok D Bus 7001, B-3000 Leuven, Belgium.-
local.description.affiliation[Penders, Joris] Ziekenhuis Oost Limburg ZOL, Dept Clin Biol, Genk, Belgium.-
local.description.affiliation[Penders, Joris; Mullens, Wilfried] Hasselt Univ, Biomed Res Inst, Fac Med & Life Sci, Diepenbeek, Belgium.-
local.description.affiliation[Vercammen, Jan; Mullens, Wilfried] Ziekenhuis Oost Limburg ZOL, Dept Cardiol, Genk, Belgium.-
local.description.affiliation[Droogne, Walter; Janssens, Stefan] Katholieke Univ Leuven, Univ Hosp Leuven, Dept Cardiovasc Dis, Leuven, Belgium.-
local.uhasselt.internationalno-
item.fullcitationSmeets , Miek; Raat, Willem; Aertgeerts, Bert; PENDERS, Joris; Vercammen, Jan; Droogne, Walter; MULLENS, Wilfried; Janssens , Stefan & Vaes, Bert (2023) Mixed-methods evaluation of a multifaceted heart failure intervention in general practice: the OSCAR-HF pilot study. In: ESC Heart Failure, 10 (2) , p. 907 -916.-
item.contributorSmeets , Miek-
item.contributorRaat, Willem-
item.contributorAertgeerts, Bert-
item.contributorPENDERS, Joris-
item.contributorVercammen, Jan-
item.contributorDroogne, Walter-
item.contributorMULLENS, Wilfried-
item.contributorJanssens , Stefan-
item.contributorVaes, Bert-
item.fulltextWith Fulltext-
item.accessRightsOpen Access-
crisitem.journal.issn2055-5822-
crisitem.journal.eissn2055-5822-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
ESC Heart Failure - 2022 - Smeets - Mixed‐methods evaluation of .pdfPublished version328.18 kBAdobe PDFView/Open
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.